Jiayu Wang

Phase I Study and Biomarker Analysis of Pyrotinib, a Novel Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Fei Ma, Qiao Li, Shanshan Chen et al. · Journal of Clinical Oncology · 2017 · 228 citations

Metastatic Breast Cancer, Oncology, Biomarker Analysis +12

Group <scp>IIc WRKY</scp> transcription factors regulate cotton resistance to <i>Fusarium oxysporum</i> by promoting <scp>GhMKK2</scp>‐mediated flavonoid biosynthesis

Lijun Wang, Dezheng Guo, Guangdong Zhao et al. · New Phytologist · 2022 · 115 citations

Engineering, Plant Defense Gene, Genetics +21

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer

Xiuwen Guan, Fei Ma, Chunxiao Li et al. · Cancer Communications · 2019 · 113 citations · Full text

Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial

Pin Zhang, Yi Yin, Hongnan Mo et al. · Oncotarget · 2016 · 95 citations · Full text

Effects of PEO−PPO−PEO Triblock Copolymers on Phospholipid Membrane Integrity under Osmotic Stress

Jiayu Wang, Jaemin Chin, Jeremy D. Marks et al. · Langmuir · 2010 · 58 citations · Full text